In equivocal cases, when both the corpus and the cervix are involved identifying the primary site of tumor by evaluating curettage or hysterectomy specimens may be impossible without the use of a panel of immunostaining which includes P16, estrogen receptor, progesterone receptor, vimentin, and carcinoembryonic antigen14. The gene discussed is ESR1; the disease is neoplasm.